[
    [
        {
            "time": "2018-03-01",
            "original_text": "医药与健康护理行业月报：重点关注意外、一季报超预期个股",
            "features": {
                "keywords": [
                    "医药",
                    "健康护理",
                    "一季报",
                    "超预期"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "健康护理"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药与健康护理行业月报：重点关注意外、一季报超预期个股",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "辉立证券：汽车航空、环保公用、医药消费行业研究报告",
            "features": {
                "keywords": [
                    "汽车航空",
                    "环保公用",
                    "医药消费"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "汽车航空",
                    "环保公用",
                    "医药消费"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "辉立证券：汽车航空、环保公用、医药消费行业研究报告",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "【医药】江琦：医药生物行业2018年3月月报：以业绩为导向，以创新为方向",
            "features": {
                "keywords": [
                    "医药生物",
                    "业绩",
                    "创新"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药】江琦：医药生物行业2018年3月月报：以业绩为导向，以创新为方向",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        }
    ]
]